pre-IPO PHARMA
COMPANIES VC JOBS NEWS CONTACT

COMPANY OVERVIEW

Gliknik is a privately held biopharmaceutical company working to ease human suffering by creating new therapies for people living with cancer and immune disorders.

LOCATION

  • Baltimore, MD, USA

    • THERAPEUTIC AREAS

  • Immunology

  • Oncology

    • WEBSITE

    https://www.gliknik.com/

    CAREER WEBSITE

    https://www.gliknik.com/contact-us/careers/

    SOCIAL MEDIA

    INVESTORS

    brace-pharma-capital lifetech-research maryland-health-care-product-development-corporation shire

    PRESS RELEASES


    Jun 24, 2021

    Gliknik Inc. Raises $11.5 Million in Series C Financing


    Feb 19, 2019

    Gliknik To Receive $15 Million Milestone Payment From Pfizer Inc. Following Clinical Progress With PF-06755347, Previously Known As GL-2045


    Apr 3, 2018

    Gliknik Announces Issuance of U.S. Patent for Use of Recombinant IVIG Mimetics


    Aug 28, 2017

    Gliknik Announces Dosing Of First Patient In Phase 2 Trial Targeting Prevention Of Recurrence Of High-Risk Oral Cavity Cancer


    Feb 19, 2014

    Gliknik Expands Clinical Development Team with New Senior Director and Adds Board Members


    For More Press Releases
    Google Analytics Alternative